Who is sponsoring NCT07461701?

NCT07461701 is sponsored by University of Health Sciences Lahore.

What drugs are being tested in NCT07461701?

Interventions in NCT07461701: Body-weight squat training (15% velocity loss threshold), Body-weight squat training (30% velocity loss threshold).

What condition does NCT07461701 study?

NCT07461701 studies Lower-Limb Strength, Muscular Endurance, Velocity-Based Resistance Training.

Is NCT07461701 still recruiting?

NCT07461701 is currently recruiting now. Last updated 10 March 2026.

Last reviewed 2026-03-10 · How we verify

NCT07461701

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study of 15% Versus 30% Velocity Loss Thresholds During Bodyweight Squats and Their Effects on Strength and Endurance in Young Women

Recruiting now NA Last updated 10 March 2026

What this trial tests

NA trial testing Body-weight squat training (15% velocity loss threshold) in Lower-Limb Strength in 52 participants. Currently enrolling.

Timeline

22 February 2026

Primary endpoint
5 April 2026

19 April 2026

Quick facts

Lead sponsor	University of Health Sciences Lahore
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	52
Start date	22 February 2026
Primary completion	5 April 2026
Estimated completion	19 April 2026
Sites	1 location across Pakistan

Drugs / interventions tested

Body-weight squat training (15% velocity loss threshold)
Body-weight squat training (30% velocity loss threshold)

Conditions studied

Lower-Limb Strength — all drugs for Lower-Limb Strength →
Muscular Endurance — all drugs for Muscular Endurance →
Velocity-Based Resistance Training — all drugs for Velocity-Based Resistance Training →

Sponsor

University of Health Sciences Lahore

Who can join

Adults 18 to 25, female only, with Lower-Limb Strength or Muscular Endurance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to learn how two different velocity loss thresholds (15% and 30%) during bodyweight squats affect strength and endurance in non-athletic young women aged 18-25 years. The main questions it aims to answer are: Does a lower velocity loss threshold (15%) during bodyweight squats improve lower-limb strength? Does a higher velocity loss threshold (30%) during bodyweight squats improve muscular endurance? Researchers will compare the two groups (15% vs. 30% velocity loss) to see if one approach works better for strength and endurance. Participants will: Perform bodyweight squats three times per week for six weeks. Be randomly assigned to either the 15% or 30% velocity loss group. Complete strength and endurance tests before and after the program

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Health Sciences Lahore trials

Trials by the same sponsor.

NCT07484178 — Effectiveness of Nurse-Led Interventions on Respiratory Outcomes in Hospitalized Patients With Acute Exacerbation of Chr · NA · not yet recruiting
NCT07526623 — Combined Effect of Benson Relaxation Technique and Jacobson Progressive Muscle Relaxation Exercises on Premenstrual Synd · NA · active not recruiting
NCT07467070 — Effectiveness of Pilates on Postural Correction, Core Strength and Flexibility in Younger Individuals With Non-specific · NA · recruiting
NCT07467044 — Combined Effects of Dead Bug Exercise and Double Straight Leg Raises Versus Conventional Physical Therapy Exercise on Co · NA · active not recruiting
NCT07438834 — Continuous Sedation vs Daily Sedation Interruption in Ventilated Children · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07461701 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Health Sciences Lahore
Last refreshed: 10 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07461701.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing